Amphenol: A Clash of Investment Titans

A fascinating divergence is unfolding in Amphenol’s shareholder base. While major financial institutions are making billion-dollar bets on the technology components manufacturer, the company’s own executives are liquidating millions in stock. This fundamental conflict presents a crucial puzzle for investors: Do corporate insiders possess knowledge that the large investment firms are missing?

The financial results provide compelling evidence for the bullish case. For the third quarter of 2025, Amphenol reported adjusted earnings of $0.93 per share, significantly surpassing analyst expectations of $0.79. The revenue performance proved even more impressive, reaching $6.19 billion and exceeding forecasts by a substantial $650 million. This represents remarkable year-over-year growth exceeding 53%, underscoring the company’s strong operational execution.

Executive Read more...